Renascience
4889
Abeja
5574
Moriya
1798
Copa
7689
SHANON
3976
(Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | (Q3)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -8.65%1.2B | -7.43%1.03B | 7.79%4.84B | -10.43%1.16B | 23.08%1.25B | 15.11%1.31B | 7.53%1.11B | -6.88%4.49B | 17.65%1.3B | -18.96%1.02B |
Cost of revenue | -9.37%763.41M | 0.36%727.94M | 10.23%3.21B | -1.74%801.94M | 28.43%837.46M | 19.08%842.36M | -1.15%725.33M | -7.13%2.91B | 8.81%816.17M | -18.75%652.07M |
Gross profit | -7.35%435.04M | -22.03%301.73M | 3.29%1.63B | -25.21%358.73M | 13.50%413.22M | 8.63%469.55M | 28.73%387.01M | -6.42%1.58B | 36.52%479.64M | -19.33%364.06M |
Operating expense | 4.70%329.77M | -3.22%327.03M | 11.14%1.3B | 21.80%311.03M | 13.30%336.1M | -1.44%314.96M | 13.33%337.92M | 6.57%1.17B | 0.94%255.35M | 2.41%296.66M |
Staff costs | 3.28%130.48M | -2.76%129.87M | 4.89%583.44M | 0.45%237.61M | 16.57%85.94M | -4.48%126.34M | 17.47%133.55M | 16.57%556.22M | 5.23%236.54M | 43.70%73.73M |
Selling and administrative expenses | ---- | ---- | 21.19%62M | ---- | ---- | ---- | ---- | 16.28%51.16M | ---- | ---- |
-General and administrative expense | ---- | ---- | 21.19%62M | ---- | ---- | ---- | ---- | 16.28%51.16M | ---- | ---- |
Research and development costs | ---- | ---- | 83.45%52.64M | ---- | ---- | ---- | ---- | -54.19%28.69M | ---- | ---- |
Depreciation and amortization | ---- | ---- | 8.86%15.49M | ---- | ---- | ---- | ---- | 33.29%14.23M | ---- | ---- |
-Depreciation | ---- | ---- | 8.86%15.49M | ---- | ---- | ---- | ---- | 33.29%14.23M | ---- | ---- |
Other operating expenses | 5.66%199.29M | -3.52%197.16M | 12.90%586.43M | 24.66%-56.71M | 12.21%250.16M | 0.70%188.62M | 10.78%204.36M | 3.24%519.44M | 15.51%-75.28M | -6.47%222.93M |
Operating profit | -31.91%105.27M | -151.53%-25.3M | -19.26%328.5M | -78.73%47.71M | 14.41%77.11M | 37.18%154.59M | 1,888.29%49.09M | -30.72%406.85M | 128.03%224.29M | -58.30%67.4M |
Net non-operating interest income (expenses) | ||||||||||
Net investment income | 73K | -1.7M | -102.33%-43K | -38K | 97.33%-2K | 61.50%1.85M | 0 | 39.52%-75K | ||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 12,692.17%88.4M | 0 | 0 | 0 | 88.4M | -702K | -702K | 0 | ||
Income from associates and other participating interests | 7.94M | 10.52M | ||||||||
Special income (charges) | 585,087.84%865.78M | 586,750.68%868.24M | 0 | 0 | -2.46M | 99.59%-148K | -148K | 0 | ||
Less:Other special charges | ---- | ---- | ---865.78M | ---868.24M | --0 | --0 | --2.46M | ---- | ---- | ---- |
Less:Write off | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -99.59%148K | ---- | ---- |
Other non-operating income (expenses) | 3,971.88%1.3M | 174.24%362K | 1.43%7.6M | -85.71%884K | 1,076.30%6.55M | -51.52%32K | -80.73%132K | 1,132.40%7.49M | 206,066.67%6.19M | 55,800.00%557K |
Income before tax | -25.89%114.58M | -111.92%-16.11M | 210.65%1.29B | 299.26%916.79M | 23.24%83.66M | 34.82%154.62M | 4,197.55%135.16M | -24.92%415.34M | 133.86%229.62M | -57.97%67.89M |
Income tax | -33.17%31.58M | -125.38%-9.14M | 155.69%345.78M | 229.46%239.52M | -8.44%23M | 35.52%47.26M | 1,315.85%36.01M | -16.60%135.24M | 112.52%72.7M | -38.24%25.12M |
Net income | -22.69%83M | -107.03%-6.97M | 237.18%944.46M | 331.60%677.28M | 41.85%60.67M | 34.52%107.36M | 16,370.43%99.15M | -28.36%280.1M | 145.27%156.92M | -64.61%42.77M |
Net income continuous operations | -22.69%83M | -107.03%-6.97M | 237.18%944.46M | 331.60%677.28M | 41.85%60.67M | 34.52%107.36M | 16,370.60%99.15M | -28.36%280.1M | 145.28%156.92M | -64.61%42.77M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -23.62%82M | -107.03%-6.97M | 237.18%944.46M | 331.60%677.28M | 41.85%60.67M | 34.52%107.36M | 16,370.43%99.15M | -28.36%280.1M | 145.27%156.92M | -64.61%42.77M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -23.62%82M | -107.03%-6.97M | 237.18%944.46M | 331.60%677.28M | 41.85%60.67M | 34.52%107.36M | 16,370.43%99.15M | -28.36%280.1M | 145.27%156.92M | -64.61%42.77M |
Gross dividend payment | ||||||||||
Basic earnings per share | -22.66%7.61 | -108.15%-0.74 | 237.67%86.51 | 332.03%62.04 | 41.58%5.55 | 34.98%9.84 | 18,060.00%9.08 | -27.83%25.62 | 147.16%14.36 | -64.27%3.92 |
Diluted earnings per share | -23.62%7.5105 | -108.15%-0.74 | 237.67%86.51 | 332.00%62.0347 | 41.68%5.55 | 34.89%9.8336 | 18,060.00%9.08 | -27.83%25.62 | 147.29%14.36 | -64.29%3.9173 |
Dividend per share | 0 | 0 | 25.00%10 | 25.00%10 | 0 | 0 | 0 | -27.27%8 | -27.27%8 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
See the daily top gainer.